Drug Research
Novartis and Versant Ventures Launch Borealis Biosciences with $150M Investment
Novartis and Versant Ventures have launched Borealis Biosciences with a substantial $150 million Series A funding. The new biotech firm aims to develop next-generation xRNA-based medicines targeting kidney diseases. This venture marks a significant milestone in renal medicine and...
Drug Research
Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program
Bridge Biotherapeutics, a clinical-stage biotech company announced that it has entered into a joint research agreement with HitGen Inc., a Chinese drug discovery platform company. This collaboration builds on successful initial hit finding and identification work from HitGen's DNA-encoded...
Drug Research
FUJIFILM Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facility
FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies, and oncolytic viruses hosted a celebration for the opening of its microbial fermentation manufacturing facility in Billingham. This new facility triples existing...
Drug Research
Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer Therapeutic
Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced that it has entered into a Master Services Agreement with Aronnax, Inc. for its HT-KIT cancer therapeutic.
HT-KIT research, which was conducted at NC State University to evaluate the efficacy of HT-KIT...
Drug Research
Tonix advances development of TNX-801 to prevent mpox infection
Tonix Pharmaceuticals Holding Corp., a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, has reiterated its commitment to advance development of its live attenuated virus vaccine, TNX-801 , for preventing mpox and other infectious diseases....
Drug Research
Nuntius Therapeutics Announces Collaboration with Taiho Pharmaceutical to Develop Next-Generation mRNA Therapies
Nuntius Therapeutics, a biotech company developing transformative mRNA therapies through their advanced delivery technology announced that they have entered into a collaboration agreement with Taiho Pharmaceutical Co., Ltd. (“Taiho”), a leading company in Japan for developing innovative medicines for...
Drug Research
Nanoform and Takeda to Collaborate on Plasma-Derived Therapy Formulation
Nanoform Finland Plc , the medicine performance-enhancing company announced that it is to enter into a pre-clinical development agreement with the Plasma-derived Therapies Business Unit of Takeda Pharmaceuticals, Inc., the R&D-driven biopharmaceutical company headquartered in Japan, to develop innovative...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.